Results 31 to 40 of about 163,967 (239)

Clinical value of sentinel lymph node biopsy in patients with cutaneous and acral melanoma [PDF]

Zhongguo aizheng zazhi, 2022
Background and purpose: For cutaneous and acral malignant melanoma, sentinel lymph node biopsy (SLNB) is an effective tool to evaluate the situation of regional lymph node metastasis and to determine the pathological stage.
ZOU Zijian, SUN Wei, HU Tu, WANG Chunmeng, YAN Wangjun, LUO Zhiguo, LIU Xin, ZHONG Jingqin, LIN Xinyi, XU Yu, CHEN Yong
doaj   +1 more source

Treatment options for PNET liver metastases. a systematic review [PDF]

, 2018
Pancreatic neuroendocrine tumors (PNETs) are rare pancreatic neoplasms. About 40-80% of patients with PNET are metastatic at presentation, usually involving the liver (40-93%). Liver metastasis represents the most significant prognostic factor.
Aurello, Paolo, Crovetto, Anna, Debs, Tarek, Mangogna, Livia Maria, Moschetta, Giovanni, Nigri, Giuseppe, Persechino, Raffaello, Petrucciani, Niccolò, Ramacciato, Giovanni   +8 more
core   +1 more source

Duodenal carcinoid tumour – a case report [PDF]

, 2020
Duodenal carcinoids are rare tumours of the small intestine with heterogenous clinical and pathological characteristics. The long-term prognosis is very good if discovered in the early stages.
Alexescu, Teodora Gabriela, Buchman, Cristina, Domsa, Iacob, Milaciu, Mircea, Negrean, Vasile, Orasan, Olga Hilda, Para, Ioana, Perne, Mirela Georgiana   +7 more
core   +2 more sources

Biomarkers in neuroendocrine tumors

Frontiers in Bioscience, 2010
Here, we review the role of clinical biomarkers (tissue and circulating markers) in the management of neuroendocrine tumors. These tumors may originate in different organs, from cells embriologically different but expressing common phenotypic characteristics, such as the immuno-reactivity for markers of neuro endocrine differentiation (defined as "pan ...
BERRETTA M, CAPPELLANI, Alessandro, DI VITA, Maria Domenica, BERRETTA S, NASTI G, BEARZ A, TIRELLI U, CANZONIERI V.   +7 more
openaire   +6 more sources

MEN1 promotes ferroptosis by inhibiting mTOR-SCD1 axis in pancreatic neuroendocrine tumors

Acta Biochimica et Biophysica Sinica, 2022
Pancreatic neuroendocrine tumor (pNET) is the second most common malignant tumors of the pancreas. Multiple endocrine neoplasia 1 ( MEN1) is the most frequently mutated gene in pNETs and MEN1-encoded protein, menin, is a scaffold ...
Ye Zeng, Chen Haidi, Ji Shunrong, Hu Yuheng, Lou Xin, Zhang Wuhu, Jing Desheng, Fan Guixiong, Zhang Yue, Chen Xuemin, Zhuo Qifeng, Chen Jie, Xu Xiaowu, Yu Xianjun, Xu Jin, Qin Yi, Gao Heli   +16 more
doaj   +1 more source

Discussing motherhood when the oncological prognosis is dire: ethical considerations for physicians

ESMO Open, 2020
Physicians are increasingly open to discussing and supporting pregnancy after cancer treatment. However, counselling patients who are seeking pregnancy despite advanced oncological disease and/or uncertain prognosis is still challenging. Two paradigmatic
Francesca Spada, Alma Linkeviciute, Nicola Fazio, Fedro A Peccatori   +3 more
doaj   +1 more source

Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones [PDF]

, 1997
Chromogranin A (CgA) is gaining acceptance as a serum marker of neuroendocrine tumors. Its specificity in differentiating between neuroendocrine and nonneuroendocrine tumors, its sensitivity to detect small tumors, and its clinical ...
Bouillon, R. (Roger), Coopmans, W., Herder, W.W. (Wouter) de, Krenning, E.P. (Eric), Kwekkeboom, D.J. (Dirk Jan), Lamberts, S.W.J. (Steven), Lindemans, J. (Jan), Nobels, F.R.E. (Frank), Schoenmakers, C.H.H. (Christian)   +8 more
core   +4 more sources

THE GASTROINTESTINAL NEUROENDOCRIN TUMORS

Arta Medica, 2021
Objectives. The gastrointestinal neuroendocrin tumors are rare events with clinical presentation widely variable and surgical management that is often challenging. Material and methods. We performed a retrospective study in the First Surgical Clinic, St Spiridon University Hospital, “Grigore T.
Delia Ciobanu, Ludmila Lozneanu, Costel Bradea, Valeria Bătrineac, Vasilescu A, Cristian Lupașcu, C. Volovăț, N Vlad, E. Târcoveanu   +8 more
openaire   +4 more sources

Multimodality imaging differentiation of pancreatic neuroendocrine tumors and solid pseudopapillary tumors with a nomogram model: A large single-center study

Frontiers in Surgery, 2022
BackgroundPancreatic neuroendocrine tumors (pNETs) and solid pseudopapillary tumors (SPTs) are two of the most common pancreatic neoplasms with different treatment procedures.
Hai-Feng Hu, Hai-Feng Hu, Hai-Feng Hu, Hai-Feng Hu, Hai-Feng Hu, Zheng Li, Zheng Li, Zheng Li, Zheng Li, Zheng Li, Ke Chen, Meng-Qi Liu, Meng-Qi Liu, Meng-Qi Liu, Meng-Qi Liu, Meng-Qi Liu, Zeng Ye, Zeng Ye, Zeng Ye, Zeng Ye, Zeng Ye, Xue-min Chen, Yue Zhang, Xian-Jun Yu, Xian-Jun Yu, Xian-Jun Yu, Xian-Jun Yu, Xian-Jun Yu, Xiao-Wu Xu, Xiao-Wu Xu, Xiao-Wu Xu, Xiao-Wu Xu, Xiao-Wu Xu, Shun-Rong Ji, Shun-Rong Ji, Shun-Rong Ji, Shun-Rong Ji, Shun-Rong Ji   +37 more
doaj   +1 more source

Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study

Frontiers in Endocrinology, 2018
Background: Available neuroendocrine biomarkers are considered to have insufficient accuracy to discriminate patients with gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs) from healthy controls.
Mark J. C. van Treijen, Mark J. C. van Treijen, Catharina M. Korse, Catharina M. Korse, Rachel S. van Leeuwaarde, Rachel S. van Leeuwaarde, Lisette J. Saveur, Lisette J. Saveur, Menno R. Vriens, Menno R. Vriens, Wieke H. M. Verbeek, Wieke H. M. Verbeek, Margot E. T. Tesselaar, Margot E. T. Tesselaar, Gerlof D. Valk, Gerlof D. Valk   +15 more
doaj   +1 more source